Undisclosed Industry Payments Rampant in Drug-Trial Papers

A recent study highlighted by Nature showed that roughly 25% of Australian medical researchers involved in clinical trials did not declare funding from pharmaceutical companies. This aligns with studies of researchers in clinical trials in the U.S., suggesting a pervasive challenge that transcends borders.